Open Science Prize results for OpenTrialsFDA + feedback

After reaching the final three of the Open Science Prize, and being judged by an expert panel, we can announce that our project, OpenTrialsFDA was placed as a runner-up alongside MyGene2, with Real-Time Evolutionary Tracking for Pathogen Surveillance and Epidemiological Investigation being declared the winner of the grand prize of $230,000. As you may know, […]

Read More

Upcoming events: OpenTrials at Cochrane UK and Clinical Innovation & Partnering World

On 9th March, our Community Manager,  Ben Meghreblian, will participate in two sessions at Clinical Innovation and Partnering World in London. The event is a great opportunity for OpenTrials as it brings together leading experts in the fields of clinical innovation, outsourcing, alliance management and strategic partnering, with attendees from big pharma, biotechnology/technology firms, and […]

Read More

OpenTrialsFDA voted into top 3 of Open Science Prize

We are happy to announce that OpenTrialsFDA was voted as one of the top 3 finalists of the Open Science Prize, thereby making it to the final round. During the public voting process (1 December – 6 January) over 3700 people from 77 countries participated. Alongside OpenTrialsFDA, the prototypes with the highest percentage of votes […]

Read More

Help OpenTrialsFDA rescue “MIA” drug approval packages

OpenTrialsFDA works on making clinical trial data from the FDA (the US Food and Drug Administration) more easily accessible and searchable. For every instance in which the FDA has approved a drug for an indication, the FDA will have reviewed the pertinent data on efficacy, safety, etc., and the resulting review documents are incorporated into a […]

Read More

Data Journalism Hack Day and Bioinformatics & Data Analytics Meetup

On the 1st and 2nd of December, our Community Manager, Ben Meghreblian, was out spreading the word about OpenTrials in London. Firstly, we were invited to talk to the members of the London Containing Bioinformatics & Data Analytics Meetup – they’re a mix of bio/health/medical informaticians, machine learners, software developers, engineers, and data scientists, so […]

Read More

OpenTrials at Cochrane Colloquium

Earlier this year, two weeks after the beta launch of OpenTrials, two members of our team, Ben Meghreblian (Community Manager) and Jessica Fleminger (Researcher) travelled to the Cochrane Colloquium in Seoul to talk about OpenTrials. As you may know, we are keen to speak to different users of OpenTrials to better understand how it works […]

Read More

OHSU Open Science Data Jamboree & Hackathon

* This event was originally scheduled to take place on Friday 16 December, but due to conditions at OHSU it will be rescheduled to another date in the near future. OpenTrialsFDA will be featured in the OHSU (Oregon Health & Science University) Open Science Data Jamboree & Hackathon. The event will focus on the power of […]

Read More

OpenTrialsFDA presents prototype as finalist for the Open Science Prize

Open Knowledge International is thrilled to announce that the OpenTrialsFDA team is presenting its prototype today at the BD2K Open Data Science Symposium in Washington, DC as finalist for the Open Science Prize. The Open Science Prize is a global science competition to make both the outputs from science and the research process broadly accessible. […]

Read More

OpenTrialsFDA – Frequently Asked Questions

The OpenTrialsFDA team, which is in the running for the Open Science Prize thanks to funding of the Wellcome Trust, the US National Institutes of Health (NIH) and the Howard Hughes Medical Institute, will present the prototype of the new OpenTrialsFDA interface at the BD2K Open Data Science Symposium on 1 December 2016. Following the […]

Read More

AllTrials interview: Ben Meghreblian, OpenTrials community manager

Last month our OpenTrials community manager Ben Meghreblian sat down to talk to AllTrials campaign manager Dr Till Bruckner about the public beta launch of OpenTrials. AllTrials (http://www.alltrials.net) campaigns for all clinical trials – past, present and future – to be registered, and their methods and results to be fully reported, and thus its work is […]

Read More